What is CRDO's health score?

Credo Technology Group Holding Ltd (CRDO) has a TradeApes health score of 64 out of 100, rated Healthy. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is CRDO's estimated fair value?

Based on our 5-year discounted cash flow model, Credo Technology Group Holding Ltd's estimated fair value is $N/A per share. This is a model estimate, not a price target or investment recommendation.

Is CRDO undervalued or overvalued?

Our model currently rates CRDO as Overvalued. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

To Unlock Full Report

4 free score cards remaining

Credo Technology Group Holding Ltd (CRDO)

Technology Overvalued medium healthy

$202.68

Updated: 2026-07-18

TradeApes Score

Financial Strength

80 Strong

Operating Trend

93 Strong

Relative Value

30 Weak

Capital Allocation

35 Weak

Risk Management

80 Strong

Key Findings

+ Net cash position — more cash on hand than total debt

Unlock Full Report →

− Extreme P/E — above 45×, very high expectations embedded in price

Unlock Full Report →

Industry Related Stocks

APPLIED OPTOELECTRONICS, INC. (AAOI) ANALOG DEVICES INC (ADI) ADVANTEST CORP (ADTTF) Arteris, Inc. (AIP) Astera Labs, Inc. (ALAB) ALLEGRO MICROSYSTEMS, INC. (ALGM)

See all Technology stocks →

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.